Brief: Mithra Pharmaceuticals H1 Net Loss Widens To 54.9 Million Euros

Mithra Pharmaceuticals SA

24/09/2021 06:40

Sept 24 (Reuters) - MITHRA PHARMACEUTICALS SA  MITRA.BR :
    * END-H1 EUR 56 MILLION CASH POSITION
    * H1 EBITDA LOSS EUR 31.9 MILLION VERSUS LOSS EUR 30 MILLION
YEAR
AGO
    * STILL AROUND EUR 290 MILLION CASH TO BE COLLECTED FOR
ESTELLE
OUT-LICENSING AND SALES RELATED MILESTONES
    * H1 NET LOSS OF EUR 54.9 MILLION VERSUS LOSS EUR 34 MILLION
YEAR
AGO
    * H1 REVENUE EUR 12.1 MILLION VERSUS EUR 2.5 MILLION YEAR
AGO

Source text for Eikon:  ID:nNDL5TBJT2 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))